RecruitingEarly Phase 1NCT06828341

A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression

Studying Embryonal tumor of neuroepithelial tissue

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
JIANG LONGWEI
Principal Investigator
Jia Shaochang, doctor
Jinling Hospital, China
Intervention
CAR-T(biological)
Enrollment
3 target
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

Nanjing Kanghe Cell Gene Engineering Research Institute Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06828341 on ClinicalTrials.gov

Other trials for Embryonal tumor of neuroepithelial tissue

Additional recruiting or active studies for the same condition.

See all trials for Embryonal tumor of neuroepithelial tissue

← Back to all trials